SHOCKING DRUG RECALL: 11,000+ Blood Pressure Pills CONTAMINATED! Is YOURS Affected?
Could your blood pressure medication secretly contain a different drug? A New Jersey drugmaker, Glenmark Pharmaceuticals Inc., has voluntarily recalled thousands of bottles of a combination high blood pressure medication, raising serious concerns. This alarming move comes after reserve samples of bisoprolol fumarate and hydrochlorothiazide tablets, sold under the Ziac brand, tested positive for ezetimibe, a drug intended for high cholesterol. Although the Federal Drug Administration (FDA) has classified this as a Class III recall, indicating a low likelihood of adverse health consequences, it spotlights critical questions about pharmaceutical manufacturing oversight. The recall affects over 11,100 bottles in various counts and dosages, with specific NDC and lot numbers identified. Consumers should be vigilant and check their medications for the affected batches, which have expiration dates extending into 2025 and 2026. This incident highlights the paramount importance of rigorous quality control in pharmaceutical production to ensure patient safety. It serves as a potent reminder for patients to stay informed about their prescriptions and any potential recalls. For more crucial health updates and consumer alerts that could impact your family, make sure to subscribe to our channel!
Tags/Hashtags: #Highbloodpressure #medicationrecall #FDA #GlenmarkPharmaceuticals #Ziac #Bisoprololfumarate #Hydrochlorothiazide #Ezetimibe #Drugcontamination #Pharmaceuticalrecall #FederalDrugAdministration(FDA) #GlenmarkPharmaceuticalsInc. #NewJersey #ElmwoodPark #voluntarydrugrecall #medicationcrosscontamination
About the Author
